Curie Ai

CurieAI, based in Santa Clara, CA, addresses the challenges faced by the approximately 40 million individuals suffering from asthma and COPD in the U.S. The company offers an innovative solution that utilizes advanced AI technology and connected devices for continuous, objective respiratory care, enhancing patient compliance and treatment effectiveness.

Through its patented technology, CurieAI enables ongoing symptom assessment and medication usage without requiring active participation from patients. This proactive approach not only aids clinicians in monitoring patient conditions outside of traditional clinical settings but also helps healthcare systems and payers to manage chronic populations effectively, ultimately reducing costs associated with emergency care and hospitalizations.

Generated from the website